The briefing
Long-term ALLEGRO extension data indicate ritlecitinib (Litfulo) maintains durable hair regrowth in severe alopecia areata through three years. The report underscores persistence of benefit over extended follow-up.
Original headline
Ritlecitinib Sustains Hair Regrowth in Alopecia Areata Through 3 Years